Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Steven Nickolas is a writer and has 10+ years of experience working as a consultant to retail and institutional investors. Charlene Rhinehart is a CPA , CFE, chair of an Illinois CPA Society committee ...
Apr. 9, 2025 Researchers analyzed trade-related risks to energy security across 1,092 scenarios for cutting carbon emissions by 2060. They found that swapping out dependence on imported fossil fuels ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results